Rejuvenation Strategy for Inducing and Enhancing Autoimmune Response to Eliminate Senescent Cells
Xingyue Wang1, Chengyu Zhang1, Jiahong Su1
1Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, China.
Aging and Disease
|August 9, 2024
Summary
Immunotherapy, including CAR-T cell therapy, shows promise in clearing senescent cells to combat aging and age-related diseases. Eliminating these cells enhances the body's repair capacity, potentially slowing the aging process.
Area of Science:
- Gerontology
- Immunology
- Cell Biology
Background:
- Aging is characterized by progressive bodily changes and increased susceptibility to age-related diseases.
- Cellular senescence, the accumulation of senescent cells, is a key driver of aging and disease.
- Eliminating senescent cells can improve tissue repair and potentially slow aging.
Purpose of the Study:
- To provide an overview of the 12 Hallmarks of aging.
- To explore the potential of various immunotherapies for eliminating senescent cells.
- To highlight novel approaches for age-related research.
Main Methods:
- Overview of the 12 Hallmarks of aging.
- Review of immune checkpoint blockade strategies.
- Exploration of innate immune cell therapies (T cells, iNKT cells, macrophages, NK cells).
- Discussion of Chimeric Antigen Receptor (CAR)-T, CAR-NK, and CAR-M cell therapies.
Main Results:
- Senescent cell accumulation drives age-related diseases.
- Immunotherapies can be engineered to target and eliminate senescent cells.
- Targeting senescent cells with immunotherapy offers a novel approach to aging.
Conclusions:
- Immunotherapy represents a promising strategy for combating aging.
- Targeting cellular senescence via immune cells can enhance regenerative capacity.
- This approach opens new avenues for research into age-related diseases and longevity.
Related Concept Videos
Cells of the Adaptive Immune Response
972
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
972
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Inflammatory Response
1.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.9K
Cell-mediated Immune Responses
67.9K
Overview
67.9K
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K


